drugset / Trial / NCT06058546

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

NCT06058546 ↗

Phase 2 Recruiting 180 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety of Jiuweihuaban Pill in the treatment of moderate to severe plaque psoriasis(syndrome of blood-heat ).

Timeline

Start
2023-11-23
Primary completion
2025-10
Completion
2025-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Jiuweihuaban Pill Unknown 9 g Oral
Subject Jiuweihuaban Pill Unknown 12 g Oral

Indications